AAPG officer updates share and RSU holdings

Q: What insider holdings does AAPG Chief Accounting Officer Jin Cao report in this Form 3/A?

Jin Cao reports direct ownership of 5,400 Ordinary Shares of ASCENTAGE PHARMA GROUP INTERNATIONAL and 12,883 restricted stock units (RSUs). The Form 3/A corrects an earlier omission where the ordinary shares were inadvertently not included in prior disclosure.

Q: How do the restricted stock units reported for AAPG’s Jin Cao vest?

The 12,883 RSUs vest in four equal increments on November 26 of 2026, 2027, 2028 and 2029. As each portion vests, it converts into the right to receive one Ordinary Share per RSU, supporting long-term equity compensation.

Q: What does each RSU represent for ASCENTAGE PHARMA (AAPG) Chief Accounting Officer Jin Cao?

Each restricted stock unit represents a contingent right to receive one Ordinary Share of ASCENTAGE PHARMA GROUP INTERNATIONAL upon vesting. This means Jin Cao’s RSUs turn into ordinary shares over time as vesting milestones are reached.

Q: Why was this Form 3/A amendment filed for AAPG’s Jin Cao?

The amendment states that the ordinary shares held by the reporting person “were inadvertently not included” previously. Form 3/A therefore corrects Jin Cao’s reported holdings to show both the 5,400 Ordinary Shares and 12,883 RSUs accurately.

Q: Do the RSUs held by AAPG’s Jin Cao have an expiration date?

The filing explains that the restricted stock units have no expiration date. They vest in four equal annual installments starting November 26, 2026. Once vested, each RSU entitles Jin Cao to receive one Ordinary Share of the issuer.

ASCENTAGE PHARMA GROUP INTERNATIONAL filed an amended insider ownership report for Chief Accounting Officer Jin Cao.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

3/A

Rhea-AI Filing Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL filed an amended insider ownership report for Chief Accounting Officer Jin Cao. The filing shows direct ownership of 5,400 Ordinary Shares, which had been inadvertently omitted previously, and 12,883 restricted stock units (RSUs).

Each RSU represents a contingent right to receive one Ordinary Share upon vesting. The RSUs vest in four equal installments on November 26 of 2026, 2027, 2028 and 2029, and do not have an expiration date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Cao Jin

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
holding	Restricted stock units	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Restricted stock units — 12,883 contracts (Direct); Ordinary Shares — 5,400 shares (Direct)

Footnotes (2)

F1. The ordinary shares held by the Reporting Person were inadvertently not included.
F2. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Key Figures

Ordinary Shares held: 5,400 shares Restricted stock units: 12,883 RSUs RSU vesting schedule: 4 equal installments

3 metrics

Ordinary Shares held 5,400 shares Direct ownership reported for Jin Cao

Restricted stock units 12,883 RSUs RSUs convertible into Ordinary Shares upon vesting

RSU vesting schedule 4 equal installments Vesting on Nov 26 of 2026, 2027, 2028 and 2029

Key Terms

Restricted stock units, contingent right, vesting

3 terms

Restricted stock units financial

"Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one Ordinary Share of the Issuer upon vesting"

vesting financial

"The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider holdings does AAPG Chief Accounting Officer Jin Cao report in this Form 3/A?

Jin Cao reports direct ownership of 5,400 Ordinary Shares of ASCENTAGE PHARMA GROUP INTERNATIONAL and 12,883 restricted stock units (RSUs). The Form 3/A corrects an earlier omission where the ordinary shares were inadvertently not included in prior disclosure.

How do the restricted stock units reported for AAPG’s Jin Cao vest?

The 12,883 RSUs vest in four equal increments on November 26 of 2026, 2027, 2028 and 2029. As each portion vests, it converts into the right to receive one Ordinary Share per RSU, supporting long-term equity compensation.

What does each RSU represent for ASCENTAGE PHARMA (AAPG) Chief Accounting Officer Jin Cao?

Each restricted stock unit represents a contingent right to receive one Ordinary Share of ASCENTAGE PHARMA GROUP INTERNATIONAL upon vesting. This means Jin Cao’s RSUs turn into ordinary shares over time as vesting milestones are reached.

Why was this Form 3/A amendment filed for AAPG’s Jin Cao?

The amendment states that the ordinary shares held by the reporting person “were inadvertently not included” previously. Form 3/A therefore corrects Jin Cao’s reported holdings to show both the 5,400 Ordinary Shares and 12,883 RSUs accurately.

Do the RSUs held by AAPG’s Jin Cao have an expiration date?

The filing explains that the restricted stock units have no expiration date. They vest in four equal annual installments starting November 26, 2026. Once vested, each RSU entitles Jin Cao to receive one Ordinary Share of the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/20/2026 - 11:55 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cao Jin

(Last)

(First)

(Middle)

700 KING FARM BOULEVARD

SUITE 510

(Street)

ROCKVILLE

MARYLAND

20850

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
04/10/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	5,400	D⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted stock units	⁽²⁾	⁽²⁾	Ordinary Shares	12,883	$0	D

Explanation of Responses:

1. The ordinary shares held by the Reporting Person were inadvertently not included.

2. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Remarks:

This form is filed using a special power of attorney.

	Thomas J. Knapp	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR